SurgLine International, Inc.
SGLN
$0.00
$0.000.00%
OTC PK
| 07/31/2012 | 04/30/2012 | ||||
|---|---|---|---|---|---|
| Revenue | -134.38% | -42.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -134.38% | -42.65% | |||
| Cost of Revenue | 25.86% | -73.64% | |||
| Gross Profit | -225.49% | 72.88% | |||
| SG&A Expenses | 327.61% | -70.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -524.69% | -- | |||
| Total Operating Expenses | 98.82% | -61.86% | |||
| Operating Income | -170.58% | 65.43% | |||
| Income Before Tax | -47.51% | 66.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -47.51% | 66.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.51% | 66.12% | |||
| EBIT | -170.58% | 65.43% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -1.18% | -8.10% | |||
| Average Diluted Shares Outstanding | -1.18% | -8.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||